Clinical Trials Logo

Eating Disorders clinical trials

View clinical trials related to Eating Disorders.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 2

NCT ID: NCT02829645 Active, not recruiting - Eating Disorders Clinical Trials

Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.

Start date: February 2012
Phase: N/A
Study type: Interventional

Eating disorders (ED) are serious mental illnesses with an excess mortality and many affects in the quality of life of patients and thier relatives. Management of ED is very difficult : the prognosis remains relatively poor both in terms of remission rate and quality of life. In this context, the contribution of new strategies for pathophysiological exploration and the development of therapeutic options are crucial. In this project the investigators aim to constitute un cohort of patients from a day unit specialized in the management of ED. A prospective follow-up will be offered to patients to assess their clinical and psycho-social evolution. The overall objective is to identify which factors are prognostic of clinical improvement of the ED. We also want to better characterize patients that will migrate from diagnosis to another.

NCT ID: NCT02601495 Active, not recruiting - Depression Clinical Trials

Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery

Start date: November 2015
Phase:
Study type: Observational

In this study the investigators will seek to improve their understanding of how positive and negative valence systems, cognition, and arousal/interoception are inter-related in disorders of trauma, mood, substance use, and eating behavior for women involved in a court diversion program in Tulsa, Oklahoma (Women in Recovery). The investigators will recruit 100 individuals and use a wide range of assessment tools, neuroimaging measures, blood and microbiome collections and behavioral tasks to complete the baseline and follow-up study visits. Upon completion, the investigators aim to have robust and reliable dimensional measures that quantify these systems and a set of assessments that should be recommended as a clinical tool to enhance outcome prediction for the clinician and assist in determining who will likely benefit from the diversion program, and to inform future revision or augmentation of the program to increase treatment effectiveness.

NCT ID: NCT01888406 Active, not recruiting - Obesity Clinical Trials

Binge Eating Self-help Treatment for University Students

BEST4US
Start date: January 2013
Phase: N/A
Study type: Interventional

BEST4US compares the effectiveness of two forms of self-help interventions that target college students, ages 18 years to 22 years, who report binge eating. The overall question is whether one or the other format will prevent excess weight gain and lead to differences in eating behaviors. The two formats are (1) "pure self-help" (receipt of a self-help program via book form or online texts) and (2) a combination of the self-help program and guidance provided by a trained peer coach over the course of 8 weekly sessions.

NCT ID: NCT01693237 Active, not recruiting - Clinical trials for Bulimia Nervosa (BN)

Improving Patient Outcome in Group Therapy for Eating Disorders

F-EAT
Start date: August 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The current trial aims to investigate the impact of continuous feedback on dropout and outcome in group therapy. The hypothesis is that continuous feedback to patient and therapist on treatment progress and alliance will 1) increase adherence and 2) increase treatment outcome.

NCT ID: NCT01567670 Active, not recruiting - Clinical trials for Binge Eating Disorder

Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray

BED
Start date: August 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators are studying a new treatment for one subtype of obesity. Obesity is not a disease. It is a symptom of several different diseases. These diseases have distinct etiologies, being caused by aberrations in different mechanisms. Forms of obesity caused by such non-critical mechanisms might be corrected fairly easily and safely. The investigators are interested in overeating and obesity that is caused by the opioidergic system. The opioidergic system appears to be responsible for a subtype of obesity associated with binge eating disorder (BED). People, especially with the right genetic predisposition, can become addicted to foods that release endorphins, in the way that people become addicted to exogenous opiates and other drugs that release endorphins. The particular application in our proposed clinical trial is for intranasal (IN) naloxone. The peak levels of naloxone were similar and the bioavailability of naloxone intranasally was 100% (the same) of that available IV." IN administration of naloxone has since been broadly tested in humans, as well, where it has been shown to be safe, with pharmacokinetics similar to those of naloxone given by injection .

NCT ID: NCT00267228 Active, not recruiting - Anorexia Nervosa Clinical Trials

Funen Anorexia Nervosa Study - Retrospective Cohort Study and 10 Year Follow-up Study

Start date: February 2006
Phase: Phase 1
Study type: Observational

The aim of the study are: 1. Retrospectively to study the clinical characteristics and features (somatic, psychological and social variables) of patients treated in Center for Eating Disorders, Odense University Hospital 1994-2004. 2. To study the predictive power of the psychosocial and morphometric data with regard to drop outs, relapse and outcome. 3. To investigate eating habits, social functions and quality of life in weight recovered and chronicly ill patients with eating disorder.